Financhill
Sell
22

VKTX Quote, Financials, Valuation and Earnings

Last price:
$41.11
Seasonality move :
40.87%
Day range:
$41.98 - $45.00
52-week range:
$17.23 - $99.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.17x
Volume:
8.7M
Avg. volume:
4.3M
1-year change:
139.78%
Market cap:
$4.7B
Revenue:
--
EPS (TTM):
-$0.93

Earnings Data

Next earnings date for VKTX
Feb 07
2025
Most recent earnings per share
-$0.22
Beat by $0.02
(Oct 23/2024)
Consensus Estimate
-$0.24
(Oct 23/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VKTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/07/2025 Q4 -- -- -- -$0.27 --
10/23/2024 Q3 -- -- -$0.22 -$0.24 $0.02
07/24/2024 Q2 -- -- -$0.20 -$0.27 $0.07
04/24/2024 Q1 -- -- -$0.26 -$0.28 $0.02
02/07/2024 Q4 -- -- -$0.25 -$0.25 -$0.00
10/25/2023 Q3 -- -- -$0.23 -$0.22 -$0.01
07/26/2023 Q2 -- -- -$0.19 -$0.20 $0.01
04/26/2023 Q1 -- -- -$0.25 -$0.24 -$0.01
02/08/2023 Q4 -- -- -$0.26 -$0.23 -$0.03
10/26/2022 Q3 -- -- -$0.21 -$0.23 $0.02
07/27/2022 Q2 -- -- -$0.23 -$0.21 -$0.02
04/27/2022 Q1 -- -- -$0.21 -$0.19 -$0.02
02/09/2022 Q4 -- -- -$0.16 -$0.19 $0.03
11/03/2021 Q3 -- -- -$0.17 -$0.21 $0.04
07/28/2021 Q2 -- -- -$0.20 -$0.20 -$0.00
04/28/2021 Q1 -- -- -$0.19 -$0.17 -$0.02
02/17/2021 Q4 -- -- -$0.15 -$0.15 $0.00
10/28/2020 Q3 -- -- -$0.13 -$0.15 $0.02
07/29/2020 Q2 -- -- -$0.13 -$0.14 $0.01
04/30/2020 Q1 -- -- -$0.13 -$0.12 -$0.01
02/26/2020 Q4 -- -- -$0.11 -$0.13 $0.02
11/05/2019 Q3 -- -- -$0.08 -$0.12 $0.04
08/01/2019 Q2 -- -- -$0.11 -$0.09 -$0.02
05/02/2019 Q1 -- -- -$0.07 -$0.09 $0.02
03/13/2019 Q4 -- -- -$0.07 -$0.10 $0.03
11/07/2018 Q3 -- -- -$0.11 -$0.12 $0.01
08/09/2018 Q2 -- -- -$0.13 -$0.12 -$0.01
05/09/2018 Q1 -- -- -$0.08 -$0.13 $0.05
03/07/2018 Q4 -- -- -$0.14 -$0.18 $0.04
11/08/2017 Q3 -- -- -$0.22 -$0.20 -$0.02
08/09/2017 Q2 -- -- -$0.21 -$0.19 -$0.02
03/31/2017 Q1 -- -- -$0.23 -$0.18 -$0.05
12/31/2016 Q4 -- -- -$0.18 -$0.22 $0.04

Viking Therapeutics Earnings Questions

  • How Much did Viking Therapeutics Generate in Revenue Last Quarter?

    Viking Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Viking Therapeutics Beat Earnings Last Quarter?

    Viking Therapeutics announced earnings per share of -$0.22 which represents a beat of analyst forecast a -$0.24 per share.

  • Is Viking Therapeutics Profitable?

    Viking Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Viking Therapeutics EPS Next Year?

    Viking Therapeutics's earnings are forecast to decrease from -$0.91 per share to -$0.92 per share next year representing a decrease of -4.95%.

  • When is Viking Therapeutics's Earnings Date?

    Viking Therapeutics's next earnings date is February 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 3.03% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 3.83% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 6.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock